Avai Bio Income Statement (2018-2025) | AVAI

Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
Cost of Revenue (Quarter)
0.25M0.22M0.15M0.33M0.01M0.10M0.21M0.04M0.03M0.00M0.01M0.15M0.08M0.06M
Gross Profit (Quarter)
-0.19M0.54M-0.09M0.29M-0.05M0.02M0.01M-0.07M1.00
Operating items
Depreciation & Amortization - Total (Quarter)
0.00M
Research & Development (Quarter)
0.02M
Selling, General & Administrative (Quarter)
0.13M0.10M0.10M0.19M0.05M0.04M0.07M0.04M0.09M0.36M0.37M0.99M-0.30M0.25M0.42M0.26M-0.18M0.21M0.27M0.19M
Other Operating Expenses (Quarter)
0.00M0.00M0.06M0.15M0.01M0.00M-0.01M0.01M0.05M0.01M0.03M0.60M0.26M0.20M0.17M0.14M0.27M0.11M0.32M
Operating Expenses (Quarter)
0.14M0.15M0.13M0.21M0.07M0.06M0.09M0.05M0.12M0.41M0.39M1.01M0.30M0.52M0.62M0.43M-0.04M0.49M0.39M0.51M
Operating Income (Quarter)
-0.02M-0.40M0.17M0.35M0.01M0.03M0.08M0.11M-1.07M0.41M0.40M1.01M-3.95M-0.53M0.62M0.45M-2.75M-0.49M-0.45M-0.55M
EBIT (Quarter)
-0.02M-0.40M0.17M0.35M0.01M0.03M0.08M0.11M-1.07M0.41M0.40M1.01M-3.95M-0.53M0.62M0.45M-2.75M-0.49M-0.45M-0.55M
Non-operating items
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)
0.01M-0.01M-0.01M-0.02M
Net income details
EBT (Quarter)
-0.02M-0.40M0.17M0.35M0.01M0.03M0.08M0.11M-1.07M-0.41M-0.40M-1.01M-3.95M-0.53M-0.62M-0.45M-2.75M-0.49M-0.45M-0.55M
Profit After Tax (Quarter)
-0.02M-0.40M0.17M0.35M0.01M0.03M0.08M0.11M-0.57M-0.41M-0.40M-1.01M-3.95M-0.53M-0.63M-0.45M0.46M-0.49M-0.45M-0.55M
Income from Non-Controlling Interests (Quarter)
-0.59M-0.39M0.19M0.35M-0.02M0.03M0.07M0.12M0.12M0.41M0.40M1.01M0.62M0.45M-0.45M-0.55M
Income from Continuing Operations (Quarter)
-0.02M-0.40M0.17M0.35M0.01M0.03M0.08M0.11M-1.07M-0.41M-0.40M-1.01M-3.95M-0.53M-0.62M-0.45M-2.75M-0.49M-0.45M-0.55M
Consolidated Net Income (Quarter)
-0.02M-0.40M0.17M0.35M0.01M0.03M0.08M0.11M-1.07M-0.41M-0.40M-1.01M-3.95M-0.53M-0.62M-0.45M-2.75M-0.49M-0.45M-0.55M
Income towards Parent Company (Quarter)
-0.02M-0.40M0.17M0.35M0.01M0.03M0.08M0.11M-1.07M-0.41M-0.40M-1.01M-3.95M-0.53M-0.62M-0.45M-2.75M-0.49M-0.45M-0.55M
Net Income towards Common Stockholders (Quarter)
-0.02M-0.40M0.17M0.35M0.01M0.03M0.08M0.11M-1.07M-0.41M-0.40M-1.01M-3.95M-0.53M0.62M0.45M-2.75M-0.49M-0.45M-0.55M
Additional items
EPS (Basic) (Quarter)
0.00-0.020.010.010.000.000.000.00-0.03-0.01-0.01-0.010.010.00-0.010.00-0.020.000.000.00
EPS (Weighted Average and Diluted) (Quarter)
Shares Outstanding (Weighted Average) (Quarter)
26.28M26.28M26.28M26.32M26.32M26.32M32.23M32.23M38.50M57.65M74.27M67.08M86.53M115.83M123.60M125.18M128.15M137.46M137.54M137.71M
Shares Outstanding (Diluted Average) (Quarter)
EBITDA (Quarter)
-0.02M-0.40M0.17M0.35M0.01M0.03M0.08M0.11M-1.07M-0.41M-0.40M-1.01M-0.30M-0.53M-0.62M-0.45M0.46M-0.49M-0.45M-0.55M